Concepedia

Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertension

Florenzo Iannone, Maria Teresa Riccardi, Serena Guiducci, R. Bizzoca, Marina Cinelli, Marco Matucci‐Cerinic, Giovanni Lapadula

Annals of the Rheumatic Diseases · 2007 · 65 citations · 19 references

DOIFull text

Open access

Concepts

References

19

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

E. Carwile LeRoy, Casilda G. Black, Raúl Fleischmajer et al. · 2001 · 4K citations

, , +10

Bosentan Therapy for Pulmonary Arterial Hypertension

Lewis J. Rubin, David B. Badesch, Robyn J. Barst et al. · New England Journal of Medicine · 2002 · 2.7K citations · Full text

, , +17

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

Richard N. Channick, G Simonneau, Olivier Sitbon et al. · The Lancet · 2001 · 1.5K citations

, , +13

Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis

Sergio A. Jiménez, Chris T. Derk · Annals of Internal Medicine · 2004 · 295 citations

, , +16

Systemic sclerosis associated pulmonary hypertension: improved survival in the current era

Mark Williams · Heart · 2005 · 236 citations · Full text

, , +10